Advertisement

Supportive Care in Cancer

, Volume 24, Issue 6, pp 2523–2531 | Cite as

Evaluation of the treatment of chronic chemotherapy-induced peripheral neuropathy using long-wave diathermy and interferential currents: a randomized controlled trial

  • Katarina LindbladEmail author
  • Leif Bergkvist
  • Ann-Christin Johansson
Original Article

Abstract

Purpose

The purpose was to investigate the effects of long-wave diathermy in combination with interferential currents (interferential therapy and long-wave diathermy at high power (ITH)) in comparison with long-wave diathermy at a power below the active treatment dose (long-wave diathermy at low power (LDL), control group) on sensory and motor symptoms in patients with chronic chemotherapy-induced peripheral neuropathy (CIPN) in the lower extremities.

Methods

Sixty-seven patients with chronic CIPN were randomized to 12 weeks of either ITH or LDL. Follow-up assessments were performed after the treatment period and at 37 weeks after randomization. The primary outcome was pain (Numeric Rating Scale (NRS)), and the secondary outcomes were discomfort, nerve symptoms, subjective measurement of dizziness (Dizziness Handicap Inventory), and balance. Differences within and between groups were analyzed.

Results

Pain intensity decreased significantly only in the LDL group directly after the treatment period from NRS median 25 to median 12.5 (P = 0.017). At the 37-week follow-up, no changes were detected, irrespective of group (NRS 13 vs. 20, P = 0.885). Discomfort decreased significantly in both groups at both 12 and 37 weeks after the baseline (P < 0.05). Balance disability showed significant declines in both groups at 12 and 37 weeks (P = 0.001/0.025 in the ITH group vs P = 0.001/<0.001 in the LDL group). Balance ability (tightened Romberg test) increased significantly at both 12 and 37 weeks in both groups (P = 0.004/<0.040 in the ITH group) but did not improve in the LDL group at any of the follow-up time points (P = 0.203 vs P = 0.383). The one-legged stance test was unchanged in the ITH group after 12 weeks but improved 37 weeks after baseline (P = 0.03). No significant changes were observed in the LDL group at any of the follow-up time points.

Conclusion

This study provides no support for the use of a combination of long-wave diathermy and ITH as a treatment option for patients with chronic CIPN. However, the chronic CIPN symptoms decreased with time irrespective of the treatment.

Keywords

Physical therapy Electrotherapy Diathermy Interferential current Cancer 

Notes

Acknowledgments

The study was supported by research grants from the Västmanland County Hospital, Västerås, Sweden. We are grateful for the support provided by physical therapists Jenny Ulmestedt and Karin Tissier Knutsgård, for helping with the assessment and evaluation of the patients. We also acknowledge Berit Werner-Erichsen, Head of Physical Therapy, Surgical Department, Västmanland County Hospital, Västerås, who gave permission for performing the study.

Compliance with ethical standards

Conflict of interest

The authors declare no conflicts of interest.

References

  1. 1.
    Grisold W, Cavaletti G, Windebank AJ (2012) Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro Oncol 14(4):iv45–iv54PubMedPubMedCentralGoogle Scholar
  2. 2.
    Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C (2007) Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs 11:901–913CrossRefPubMedGoogle Scholar
  3. 3.
    Cavaletti G, Alberti P, Frigeni B, Piatti M, Susani E (2011) Chemotherapy-induced neuropathy. Curr Treat Options Neurol 13:180–190CrossRefPubMedGoogle Scholar
  4. 4.
    Rao RD, Flynn PJ, Sloan JA, Wong GY, Novotny P, Johnson DB, et al. (2008) Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy. Cancer 112:2802–2808CrossRefPubMedGoogle Scholar
  5. 5.
    Ferrier J, Pereira V, Busserolles J, Authier N, Balayssac D (2013) Emerging trends in understanding chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep 17:364CrossRefPubMedGoogle Scholar
  6. 6.
    Stillman M, Cata JP (2006) Management of chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep 10:279–287CrossRefPubMedGoogle Scholar
  7. 7.
    Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C (2008) Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer 44:1507–1515CrossRefPubMedGoogle Scholar
  8. 8.
    Schloss JM, Colosimo M, Airey C, Masci PP, Linnane AW, Vitetta L (2013) Nutraceuticals and chemotherapy induced peripheral neuropathy (CHRONIC CIPN): a systematic review. Clin Nutr 32(6):888–893. doi: 10.1016/j.clnu.2013.04.007 CrossRefPubMedGoogle Scholar
  9. 9.
    Donald GK, Tobin I, Stringer J (2011) Evaluation of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Acupunct Med 29:230–233CrossRefPubMedGoogle Scholar
  10. 10.
    Schroeder S, Meyer-Hamme G, Epplee S (2012) Acupuncture for chemotherapy-induced peripheral neuropathy (CHRONIC CIPN): a pilot study using neurography. Acupunct Med 30:4–7CrossRefPubMedGoogle Scholar
  11. 11.
    Smith TJ, Coyne PJ, Parker GL, Dodson P, Ramakrishnan V (2010) Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-a calmare(R)) for chemotherapy-induced peripheral neuropathy. J Pain Symptom Manag 40:883–891CrossRefGoogle Scholar
  12. 12.
    Coyne PJ, Wan W, Dodson P, Swainey C, Smith TJ (2013) A trial of scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathy. J Pain Palliat Care Pharmacother 27:359–364CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Pachman DR, Weisbrod BL, Seisler DK, Barton DL, Fee-Schroeder KC, Smith TJ, et al. (2015) Pilot evaluation of scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy. Support Care Cancer 23:943–951CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Sluka KA (2009) Transcutaneous electrical nerve stimulation and interferential therapy. In: Sluka KA, Walsh D (eds) Transcutaneous electrical nerve stimulation and interferential therapy. IASP Press, Seattle, pp. 166–190Google Scholar
  15. 15.
    Interferens - Cefar. http://www.cefar.se/treatments.asp?id=&cat=Interference. Accessed 23/3, 2015
  16. 16.
    Molin B, Norrbrink C, Lundeberg T, Lund I, Lundeberg S (2010) Om smärta: ett fysiologiskt perspektiv. Studentlitteratur, LundGoogle Scholar
  17. 17.
    Johnson MI, Tabasam G (2003) An investigation into the analgesic effects of interferential currents and transcutaneous electrical nerve stimulation on experimentally induced ischemic pain in otherwise pain-free volunteers. Phys Ther 83:208–223PubMedGoogle Scholar
  18. 18.
    Johnson MI, Wilson H (1997) The analgesic effects of different swing patterns of interferential currents on cold-induced pain. Physiotherapy 83:461–467CrossRefGoogle Scholar
  19. 19.
    Stephenson R, Johnson M (1995) The analgesic effects of interferential therapy on cold-induced pain in healthy subjects: a preliminary report. Physiother Theory Pract 11:89–95CrossRefGoogle Scholar
  20. 20.
    Användarhandbok Skanlab 25 Bodywave (2004) http://skanlab.no/wp-content/uploads/2012/02/Skanlab_Usermanual_Norwegian.pdf. Accessed 23/3, 2015
  21. 21.
    ITO Physiotherapy & Rehabilitation. Elektrostimuleringsenhet ES-520 & Vakuumenhet. Device manual. PrintGoogle Scholar
  22. 22.
    Giorgi F, Cellerino R, Gramazio A, Tummarello D, Menichetti ET, Giordani P, Antognoli S, Carle F, Piga A (1996) Assessing quality of life in patients with cancer: a comparison of a visual-analogue and a categorical model. Am J Clin Oncol 19:394–399CrossRefPubMedGoogle Scholar
  23. 23.
    Jensen MP (2003) The validity and reliability of pain measures in adults with cancer. J Pain 4:2–21CrossRefPubMedGoogle Scholar
  24. 24.
    Margolis RB, Chibnall JT, Tait RC (1988) Test-retest reliability of the pain drawing instrument. Pain 33:49–51CrossRefPubMedGoogle Scholar
  25. 25.
    Ohlund C, Eek C, Palmblad S, Areskoug B, Nachemson A (1996) Quantified pain drawing in subacute low back pain. Validation in a nonselected outpatient industrial sample spine 21:1021–1030 discussion 1031Google Scholar
  26. 26.
    Jacobson GP, Newman CW (1990) The development of the dizziness handicap inventory. Arch Otolaryngol Head Neck Surg 116:424–427CrossRefPubMedGoogle Scholar
  27. 27.
    Jarlsäter S, Mattsson E (2003) Test of reliability of the dizziness handicap inventory and the activities-specific balance confidence scale for use in Sweden. Adv Physiother 5:137–144CrossRefGoogle Scholar
  28. 28.
    Briggs RC, Gossman MR, Birch R, Drews JE, Shaddeau SA (1989) Balance performance among noninstitutionalized elderly women. Phys Ther 69:748–756PubMedGoogle Scholar
  29. 29.
    Steffen T, Seney M (2008) Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item short-form health survey, and the unified Parkinson disease rating scale in people with parkinsonism. Phys Ther 88:733–746CrossRefPubMedGoogle Scholar
  30. 30.
    Pachman DR, Qin R, Seisler DK, Smith EM, Beutler AS, Ta LE, et al. (2015) Clinical course of oxaliplatin-induced neuropathy: results from the randomized phase III trial N08CB (alliance). J Clin Oncol 33:3416–3422CrossRefPubMedGoogle Scholar
  31. 31.
    Wall PD, Melzack R (1999) Textbook of pain. Churchill Livingstone, EdinburghGoogle Scholar
  32. 32.
    Rostock M, Jaroslawski K, Guethlin C, Ludtke R, Schroder S, Bartsch HH (2013) Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture. Evid Based Complement Alternat Med 2013:349653CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    FACT/GOG-NTX (Version 4) [Measurement instrument]. http://www.facit.org/LiteratureRetrieve.aspx?ID=42406. Accessed 5/11, 2015
  34. 34.
    Farrar JT, Young Jr JP, LaMoreaux L, Werth JL, Poole RM (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94:149–158CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Katarina Lindblad
    • 1
    Email author
  • Leif Bergkvist
    • 2
  • Ann-Christin Johansson
    • 3
  1. 1.Department of SurgeryVästmanland County HospitalVästeråsSweden
  2. 2.Department of Surgery, Centre for Clinical ResearchUppsala University, Västmanland County HospitalVästeråsSweden
  3. 3.Department of Physiotherapy, School of Health, Care and Social Welfare, Centre for Clinical ResearchMälardalen University, Västmanland County HospitalVästeråsSweden

Personalised recommendations